A bipartite interaction with the processivity clamp potentiates Pol IV-mediated TLS
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2421471122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Seungwoo Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115. Hauptthemen laut MEDLINE: Escherichia coli, Escherichia coli Proteins, DNA Polymerase beta, DNA-Directed DNA Polymerase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH (NIH).
Abstract (Originalsprache)
Processivity clamps mediate polymerase switching for translesion synthesis (TLS). All three Escherichia coli TLS polymerases interact with the β 2 processivity clamp through a conserved clamp-binding motif (CBM), which is indispensable for TLS. Notably, Pol IV also interacts weakly with the rim of the clamp through non-CBM residues. Ablating this “rim contact” in cells results in selective sensitivity to DNA-damaging agents, raising the question how the rim contact contributes to TLS. Here, we show that the rim contact is critical for TLS past a strong replication block but barely necessary for a weak blocking lesion. Within the in vitro reconstituted E. coli replisome, the rim mutation compromises Pol IV-mediated TLS past 3-deaza-methyl dA, a strong block, whereas barely affecting TLS past N 2 -furfuryl dG, a weak block. Similar observations are also made in E. coli cells bearing a single copy of these lesions in the genome. At lesion-stalled replication forks, single-stranded DNA binding protein locally enriches Pol IV, enabling it to bind the low-affinity rim site. This interaction poises Pol IV to better compete with Pol III, the replicative polymerase, which competitively inhibits Pol IV from interacting with the clamp through its CBM. We propose that this bipartite clamp interaction enables Pol IV to rapidly resolve lesion-stalled replication at a strong block through TLS, which reduces damage-induced mutagenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
- Cancer Research Center of Marseille: Team DNA Damage and Genome Instability|CNRS, Aix Marseille Université, Inserm, Institut Paoli-Calmettes, Marseille F-13009, France.
- School of Chemistry and Molecular Bioscience, Molecular Horizons, University of Wollongong, Wollongong, NSW 2522, Australia.
ORCID-Profile: Elizabeth S Thrall, Vincent Pagès, Joseph J Loparo
Förderung
- NIGMS NIH HHS
- HHS | NIH (NIH)
Zitieren
APA
Chang, S., Laureti, L., Thrall, E. S., Kay, M. S., Philippin, G., Jergic, S., Pagès, V., & Loparo, J. J. (2025). A bipartite interaction with the processivity clamp potentiates Pol IV-mediated TLS. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2421471122
Vancouver
Chang S, Laureti L, Thrall ES, Kay MS, Philippin G, Jergic S, et al. A bipartite interaction with the processivity clamp potentiates Pol IV-mediated TLS. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2421471122
BibTeX
@article{Chang2025,
author = {Chang, Seungwoo and Laureti, Luisa and Thrall, Elizabeth S and Kay, Marguerite S and Philippin, Gaëlle and Jergic, Slobodan and Pagès, Vincent and Loparo, Joseph J},
title = {A bipartite interaction with the processivity clamp potentiates Pol IV-mediated TLS},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2421471122}
}
EUVIMED